Technicals

Why MidWestOne (MOFG) is a Great Dividend Stock Right Now

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor’s dream. But when you’re an income investor, your primary focus is generating consistent cash flow from each of your liquid investments. While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. […]

Stock Analysts

Drillers in Permian & DJ-Niobrara Continue to Remove Oil Rigs

Baker Hughes, a GE company BHGE reported a decline in the weekly rig count in the United States. More on the Rig Count Baker Hughes’ data, issued at the end of every week since 1944, helps energy service providers gauge the overall business environment of the oil and gas industry. A change in the Houston-based oilfield service player’s rotary rig count affects demand for energy services like drilling, completion and production provided by the likes of Halliburton Company HAL , Schlumberger Limited SLB , Diamond Offshore Drilling, Inc DO and Transocean Ltd. […]

Stock Analysts

Zoom Video (ZM) to Report Q2 Earnings: What’s in Store?

Zoom Video Communications ZM is set to release second-quarter fiscal 2020 results on Sep 5. In the last reported quarter, the company posted non-GAAP earnings of 3 cents per share compared with the Zacks Consensus Estimate of a break-even. Moreover, revenues surged 103% year over year to $122 million, which comfortably surpassed the consensus mark of $110 million […]

Technicals

Why Sonoco (SON) is a Top Dividend Stock for Your Portfolio

Whether it’s through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you’re an income investor, your primary focus is generating consistent cash flow from each of your liquid investments. Cash flow can come from bond interest, interest from other types of investments, and of course, dividends […]

Stock Analysts

Akari’s Nomacopan Gets Orphan Drug Tag for Rare Disease

Akari Therapeutics, Plc AKTX announced that the FDA has granted an orphan drug designation to its lead pipeline candidate nomacopan for the treatment of hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA). Currently, there is no approved therapy for this rare disease. Notably, the orphan drug designation is granted to drugs capable of treating rare diseases that affect less than 200,000 people in the United States. […]

Stock Analysts

Cloudera (CLDR) to Report Q2 Earnings: What’s in Store?

Cloudera CLDR is set to report second-quarter fiscal 2020 results on Sep 4. The company reported adjusted loss of 13 cents per share in the first quarter, narrower than the Zacks Consensus Estimate of a loss of 23 cents and the year-ago quarter’s loss of 18 cents. Revenues of $187.5 million increased 81.2% year over year but lagged the consensus mark of $188 million […]

Stock Analysts

Is Albemarle (ALB) a Suitable Stock for Value Investors?

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process […]

Stock Analysts

Should Value Investors Consider Arkema (ARKAY) Stock Now?

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. […]